Damen, Joep <br/><br/>
A pharmacoeconomic analysis of compliance gains on antipsychotic medications.  [electronic resource] 

 -  Applied health economics and health policy  2008 
 - 189-97 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1175-5652 
<br/><br/><label>Standard No.: </label>10.1007/BF03256133  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antipsychotic Agents--economics<br/>Cost Savings<br/>Cost of Illness<br/>Cost-Benefit Analysis<br/>Direct Service Costs--statistics & numerical data<br/>Drug Costs--statistics & numerical data<br/>Economics, Pharmaceutical<br/>Health Services Research<br/>Hospitalization--economics<br/>Humans<br/>Insurance, Health, Reimbursement--economics<br/>Models, Econometric<br/>Predictive Value of Tests<br/>Quality-Adjusted Life Years<br/>Recurrence<br/>Risk Factors<br/>Risk Reduction Behavior<br/>Schizophrenia--drug therapy<br/>Severity of Illness Index<br/>Sweden<br/>Time Factors<br/>Assessment of Medication Adherence